Skip Navigation


Human Reproduction Update Advance Access originally published online on June 28, 2006
Human Reproduction Update 2006 12(5):483-497; doi:10.1093/humupd/dml028
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
12/5/483    most recent
dml028v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Hormones and cardiovascular health in women

The ESHRE Capri Workshop Group1

To whom correspondence should be addressed: P.G.Crosignani, II Department of Obstetrics and Gynecology, University of Milano, Via Commenda 12, 20122 Milano, Italy. E-mail: piergiorgio.crosignani{at}unimi.it

Cardiovascular diseases (CVDs) may have their origin before birth: the combination of being small at birth and having an overly rich post-natal diet increases the likelihood of obesity and of acquiring a specific metabolic syndrome in adulthood that carries an increased risk of CVD. The incidence of CVD and mortality is very low in women of reproductive age but rises to a significant level in older women. In this article, we discuss CVD in relation to hormonal contraception, pregnancy and polycystic ovarian syndrome (PCOS) in younger women and menopause in older women. Women with PCOS have a higher risk of diabetes and hypertension, but studies to date have not shown an effect on CVD events. Use of combined hormonal contraception has only small effects on CVD because of the low baseline incidence of myocardial infarction (MI), stroke and venous thromboembolism (VTE) among young women. Women with existing risk factors or existing CVD, however, should consider alternative contraception. In pregnancy, CVD is rare, although, in the West, it now accounts for a significant proportion of maternal mortality as the frequency of obstetrical causes of mortality has substantially declined. The frequency of VTE is 15 per 10 000 during pregnancy and the post-partum period. In older women, menopause causes a slightly higher risk of MI after allowing for age, although there is substantial heterogeneity in the results of studies on menopause and age at menopause and MI. A larger effect might have been expected, because estrogen reduces the risk of developing atherosclerosis in premenopausal women, whereas in post-menopausal women who may have established atherosclerotic disease, estrogen increases the risk of myocardial disease through the effects on plaque stability and clot formation. Recent trial results indicate that hormone treatment in menopause does not favourably affect the risk of MI, stroke or other vascular disease. Thus, prevention of CVD should rely on diet and fitness, low-dose aspirin and treatment of hypertension, hyperglycaemia and hyperlipidaemia.

Key words: cardiovascular disease / contraception / menopause / polycystic ovary syndrome / pregnancy


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 ICVTSHome page
A. E. Topal and M. N. Eren
Acute ventricular rupture due to myocardial infarction during postpartum period
Interactive CardioVascular and Thoracic Surgery, May 1, 2009; 8(5): 565 - 567.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
L. Yang, H. Kuper, S. Sandin, K. L. Margolis, Z. Chen, H.-O. Adami, and E. Weiderpass
Reproductive History, Oral Contraceptive Use, and the Risk of Ischemic and Hemorrhagic Stoke in a Cohort Study of Middle-Aged Swedish Women
Stroke, April 1, 2009; 40(4): 1050 - 1058.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
Z. Chakhtoura, M. Canonico, A. Gompel, J.-C. Thalabard, P.-Y. Scarabin, and G. Plu-Bureau
Progestogen-Only Contraceptives and the Risk of Stroke: A Meta-Analysis
Stroke, April 1, 2009; 40(4): 1059 - 1062.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
D. C. McCurnin, R. A. Pierce, B. C. Willis, L. Y. Chang, B. A. Yoder, I. S. Yuhanna, P. L. Ballard, R. I. Clyman, N. Waleh, W. Maniscalco, et al.
Postnatal Estradiol Up-regulates Lung Nitric Oxide Synthases and Improves Lung Function in Bronchopulmonary Dysplasia
Am. J. Respir. Crit. Care Med., March 15, 2009; 179(6): 492 - 500.
[Abstract] [Full Text] [PDF]

Home page
 ANGIOLOGYHome page
G. D. Kolovou and H. G. Bilianou
Influence of Aging and Menopause on Lipids and Lipoproteins in Women
Angiology, August 1, 2008; 59(2_suppl): 54S - 57S.
[Abstract] [PDF]

Home page
 AMERICAN JOURNAL OF LIFESTYLE MEDICINEHome page
K. J. Melanson
Nutrition for Women in the Prevention and Treatment of Type 2 Diabetes and Cardiovascular Diseases
American Journal of Lifestyle Medicine, June 1, 2008; 2(3): 214 - 218.
[Abstract] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. K. Snell-Bergeon, D. Dabelea, L. G. Ogden, J. E. Hokanson, G. L. Kinney, J. Ehrlich, and M. Rewers
Reproductive History and Hormonal Birth Control Use Are Associated with Coronary Calcium Progression in Women with Type 1 Diabetes Mellitus
J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2142 - 2148.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Hammer, R. W. van der Meer, H. J. Lamb, M. Schar, A. de Roos, J. W. A. Smit, and J. A. Romijn
Progressive Caloric Restriction Induces Dose-Dependent Changes in Myocardial Triglyceride Content and Diastolic Function in Healthy Men
J. Clin. Endocrinol. Metab., February 1, 2008; 93(2): 497 - 503.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
H. Roberts
Hormone replacement therapy comes full circle
BMJ, August 4, 2007; 335(7613): 219 - 220.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.